BiotechTube

Olinciguat + Matching Placebo

Phase 2Terminated
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Achalasia

Conditions

Achalasia

Trial Timeline

Apr 6, 2017 → May 1, 2018

NCT ID
NCT02931565

About Olinciguat + Matching Placebo

Olinciguat + Matching Placebo is a phase 2 stage product being developed by Cyclerion Therapeutics for Achalasia. The current trial status is terminated. This product is registered under clinical trial identifier NCT02931565. Target conditions include Achalasia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02931565Phase 2Terminated

Competing Products

1 competing product in Achalasia

See all competitors
ProductCompanyStageHype Score
Mirabegron 50 MG + PlaceboAstellas PharmaPhase 1
33

Other Products from Cyclerion Therapeutics

Matching Placebo + IW-1973Phase 2
44
IW-1701 + PlaceboPhase 2
44
IW-1973 + PlaceboPhase 2
44
IW-1701 + PlaceboPhase 1
25
[14C]-olinciguatPhase 1
25